These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12553016)

  • 1. Expression and role of thrombospondin-1 in colorectal cancer.
    Miyanaga K; Kato Y; Nakamura T; Matsumura M; Amaya H; Horiuchi T; Chiba Y; Tanaka K
    Anticancer Res; 2002; 22(6C):3941-8. PubMed ID: 12553016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of TGF-beta1, TbetaRII and Smad4 in colorectal carcinoma.
    Xu WQ; Jiang XC; Zheng L; Yu YY; Tang JM
    Exp Mol Pathol; 2007 Jun; 82(3):284-91. PubMed ID: 17289018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased TGF-beta 1 protein expression in patients with advanced colorectal cancer.
    Langenskiöld M; Holmdahl L; Falk P; Angenete E; Ivarsson ML
    J Surg Oncol; 2008 Apr; 97(5):409-15. PubMed ID: 18176914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate.
    Colombel M; Filleur S; Fournier P; Merle C; Guglielmi J; Courtin A; Degeorges A; Serre CM; Bouvier R; Clézardin P; Cabon F
    Cancer Res; 2005 Jan; 65(1):300-8. PubMed ID: 15665307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
    Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
    Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. alpha2HS-glycoprotein, an antagonist of transforming growth factor beta in vivo, inhibits intestinal tumor progression.
    Swallow CJ; Partridge EA; Macmillan JC; Tajirian T; DiGuglielmo GM; Hay K; Szweras M; Jahnen-Dechent W; Wrana JL; Redston M; Gallinger S; Dennis JW
    Cancer Res; 2004 Sep; 64(18):6402-9. PubMed ID: 15374947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific enhanced expression of platelet-derived endothelial cell growth factor in submucosa of human colorectal cancer.
    Nozawa T; Enomoto T; Koshida Y; Sato Y; Kuranami M
    Dis Colon Rectum; 2004 Dec; 47(12):2093-100. PubMed ID: 15657660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased levels of precursor transforming growth factor beta1 in human colorectal cancer.
    Dimberg J; Hugander A; Sirsjo A
    Int J Mol Med; 2001 Jun; 7(6):597-601. PubMed ID: 11351271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential role of TGFbeta1, TGFbeta2 and TGFbeta3 protein expression in colorectal carcinomas. Correlation with classic histopathologic factors and patient survival.
    Tsamandas AC; Kardamakis D; Ravazoula P; Zolota V; Salakou S; Tepetes K; Kalogeropoulou C; Tsota I; Kourelis T; Makatsoris T; Karavias D; Scopa CD; Bonikos DS; Kalofonos HP; Petsas T
    Strahlenther Onkol; 2004 Apr; 180(4):201-8. PubMed ID: 15057430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble transforming growth factor beta type II receptor attenuates TGF-beta1 activity in human colorectal cancer LoVo cells.
    Zhou R; Xiong B; Song H; Liu S; Wang X
    Oncol Rep; 2008 Dec; 20(6):1449-56. PubMed ID: 19020727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stromal thrombospondin-1 expression is correlated with progression of esophageal squamous cell carcinomas.
    Oshiba G; Kijima H; Himeno S; Kenmochi T; Kise Y; Tanaka H; Nishi T; Chino O; Shimada H; Machimura T; Tsuchida T; Nakamura M; Ueyama Y; Tanaka M; Tajima T; Makuuchi H
    Anticancer Res; 1999; 19(5C):4375-8. PubMed ID: 10650779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of thrombospondin-1 in resected colorectal liver metastases predicts poor prognosis.
    Sutton CD; O'Byrne K; Goddard JC; Marshall LJ; Jones L; Garcea G; Dennison AR; Poston G; Lloyd DM; Berry DP
    Clin Cancer Res; 2005 Sep; 11(18):6567-73. PubMed ID: 16166434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of transforming growth factor-beta activity decreases angiogenesis in a human prostate cancer-reactive stroma xenograft model.
    Tuxhorn JA; McAlhany SJ; Yang F; Dang TD; Rowley DR
    Cancer Res; 2002 Nov; 62(21):6021-5. PubMed ID: 12414622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of the alpha v beta 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival.
    Hazelbag S; Kenter GG; Gorter A; Dreef EJ; Koopman LA; Violette SM; Weinreb PH; Fleuren GJ
    J Pathol; 2007 Jul; 212(3):316-24. PubMed ID: 17503414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
    Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
    Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of transforming growth factor beta 1 (TGF beta 1) and angiogenesis in broncho-pulmonary carcinoids].
    Słodkowska J; Hasleton P; Radomski P
    Pneumonol Alergol Pol; 2000; 68(7-8):319-26. PubMed ID: 11200746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive upregulation of the transforming growth factor-beta pathway in rheumatoid arthritis synovial fibroblasts.
    Pohlers D; Beyer A; Koczan D; Wilhelm T; Thiesen HJ; Kinne RW
    Arthritis Res Ther; 2007; 9(3):R59. PubMed ID: 17594488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1.
    Qian B; Katsaros D; Lu L; Preti M; Durando A; Arisio R; Mu L; Yu H
    Breast Cancer Res Treat; 2009 Sep; 117(1):131-40. PubMed ID: 18932017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relations of transforming growth factor-beta1 expression to differentiation and prognosis of advanced gastric cancer].
    Guo RF; Zang SZ; Zhang L; Li WM; Hu FL; Lü YY
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3249-54. PubMed ID: 17313802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.